Clearwater Paper Corp
Datakwaliteit: 100%
CLW
NYSE
Manufacturing
Paper Products
€ 14,88
▼
€ 0,40
(-2,62%)
Marktkapitalisatie: 243,62 M
Prijs
€ 15,19
Marktkapitalisatie
243,62 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—
Quick Summary
Belangrijkste Punten
Revenue declined -3,22% annually over 5 years
Earnings declined -109,48% over the past year
Debt/Equity of 0,35 — conservative balance sheet
Negative free cash flow of -76,50 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 15,64%
Capital efficient — spends only 5,71% of revenue on capex
Groei
Revenue Growth (5Y)
-3,22%
Onder sectorgemiddelde (1,82%)
Revenue (1Y)12,42%
Earnings (1Y)-109,48%
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-2,30%
Boven sectorgemiddelde (-54,01%)
ROIC-2,45%
Net Margin-1,20%
Op. Margin-2,71%
Veiligheid
Debt / Equity
0,35
Boven sectorgemiddelde (0,30)
Current Ratio2,10
Interest Coverage-2,37
Waardering
PE (TTM|NTM)
-13,10 | -12,37
Onder sectorgemiddelde (-1,49)
P/B Ratio0,31
EV/EBITDA9,60
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Manufacturing sector mediaan (1385 peers)
Sectorvergelijking
vs Manufacturing sector mediaan (1385 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -13,1 | -1,5 |
| P/B | 0,3 | 1,6 |
| ROE % | -2,3 | -54,0 |
| Net Margin % | -1,2 | -41,5 |
| Rev Growth 5Y % | -3,2 | 1,8 |
| D/E | 0,4 | 0,3 |
Koersdoel Analisten
3 analisten
Buy
Huidig
€ 14,88
Koersdoel
€ 19,67
€ 16,00
€ 20,00
€ 23,00
Vooruitzicht
Forward K/W
-12,37
Forward WPA
-€ 1,20
Omzet Sch.
1,54 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2027 |
-€ 1,20
-€ 1,63 – -€ 0,55
|
1,54 B | 3 |
| FY2026 |
-€ 3,29
-€ 3,60 – -€ 2,80
|
1,47 B | 3 |
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| 2026 Q2 |
-€ 1,19
-€ 1,58 – -€ 0,53
|
368,55 M | 3 |
| 2026 Q1 |
-€ 1,32
-€ 1,36 – -€ 1,30
|
365,15 M | 3 |
Winstverassingen
Laatste 4 kwartalen
| Kwartaal | Geschat WPA | Werkelijk WPA | Verrassing |
|---|---|---|---|
| Q42025 | -€ 0,54 | -€ 0,42 | +21,5% |
| Q32025 | -€ 0,53 | -€ 0,57 | -7,7% |
| Q22025 | € 0,70 | € 0,45 | -35,4% |
| Q12025 | -€ 0,04 | -€ 0,36 | -800,0% |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 12,42% | Revenue Growth (3Y) | -13,58% |
| Earnings Growth (1Y) | -109,48% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -3,22% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1,56 B | Net Income (TTM) | -18,60 M |
| ROE | -2,30% | ROA | -1,16% |
| Gross Margin | N/A | Operating Margin | -2,71% |
| Net Margin | -1,20% | Free Cash Flow (TTM) | -76,50 M |
| ROIC | -2,45% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,35 | Current Ratio | 2,10 |
| Interest Coverage | -2,37 | Asset Turnover | 0,97 |
| Working Capital | 255,50 M | Tangible Book Value | 780,30 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -13,10 | Forward P/E | -12,37 |
| P/B Ratio | 0,31 | P/S Ratio | 0,16 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | 9,60 | Fwd EV/EBITDA | N/A |
| Forward P/S | 0,16 | Fwd Earnings Yield | N/A |
| FCF Yield | -31,40% | ||
| Market Cap | 243,62 M | Enterprise Value | 482,72 M |
| Per Share | |||
| EPS (Diluted TTM) | -1,15 | Revenue / Share | 96,98 |
| FCF / Share | -4,77 | OCF / Share | 0,77 |
| EPS CAGR (1Y) | -109,83% | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 5,71% | FCF Conversion | 411,29% |
| SBC-Adj. FCF | -79,70 M | Growth Momentum | 15,64 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,56 B | 1,38 B | 2,08 B | 2,08 B | 1,77 B |
| Net Income | -18,60 M | 196,30 M | 107,70 M | 46,00 M | -28,10 M |
| EPS (Diluted) | -1,15 | 11,70 | 6,30 | 2,68 | -1,67 |
| Gross Profit | — | 14,70 M | — | — | — |
| Operating Income | -42,10 M | -64,50 M | 177,10 M | 113,90 M | 12,00 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | — | — | — | — | — |
| SG&A Expenses | 100,80 M | 116,70 M | 148,30 M | 133,00 M | 112,90 M |
| D&A | 92,40 M | 99,80 M | 98,60 M | 103,30 M | 105,00 M |
| Interest Expense | 17,80 M | 32,00 M | 31,90 M | 34,20 M | 35,50 M |
| Income Tax | -7,10 M | -27,10 M | 36,40 M | 27,00 M | -7,70 M |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,59 B | 1,68 B | 1,67 B | 1,70 B | 1,69 B |
| Total Liabilities | 763,00 M | 824,70 M | 1,00 B | 1,13 B | 1,18 B |
| Shareholders' Equity | 825,30 M | 854,60 M | 668,80 M | 572,10 M | 511,70 M |
| Total Debt | 345,50 M | 281,60 M | 462,30 M | 564,90 M | 637,60 M |
| Cash & Equivalents | 30,70 M | 79,60 M | 42,00 M | 53,70 M | 25,20 M |
| Current Assets | 526,00 M | 545,40 M | 564,10 M | 586,30 M | 487,20 M |
| Current Liabilities | 216,20 M | 320,40 M | 286,00 M | 312,00 M | 254,10 M |
{"event":"ticker_viewed","properties":{"ticker":"CLW","listing_kind":"stock","pathname":"/stocks/clw","exchange":"NYSE","country":"US"}}






